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Abstract 
Parkin is an RBR E3 ubiquitin ligase that is implicated in the development of Parkinson’s 
Disease. Its ligase activity is specific for mitochondrial proteins, recognizing, tagging and 
signalling mitochondria to the autophagosome for degradation. Parkin contains eight Zn2+ 
binding sites and a total of 35 cysteines, which are especially susceptible to oxidative 
modification. Hallmarks of Parkinson’s Disease is oxidative stress and an increase of reactive 
oxygen species. In this work, I used biophysical methods such as mass spectrometry, CD 
spectroscopy and gel-based assays in addition to zinc and H2O2 detection methods to explore 
a potentially novel redox function for parkin. This thesis shows that parkin is capable of acting 
as a redox molecule, and oxidative modifications result in the liberation of two Zn2+ ions and 
extensive disulfide linkage formation. Parkin ubiquitination activity is also increased by mild 
oxidation but is eventually abolished. My research provides insight into novel functions of 
parkin. 
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Summary for Lay Audience 
Proteins are essential machines inside our body that carry out a variety of roles to help keep us 
healthy, aiding in digestion, growth and our immune system. When these proteins are not 
functioning properly, it is possible to give rise to many illnesses and diseases. While there are 
many thousands of proteins that have been discovered, an essential part of protein discovery is 
to discover what the protein actually looks like. Knowing the structure of a protein can provide 
very valuable information to scientists, which can in turn lead to the discovery of medicine and 
therapies used to treat these diseases. In this thesis, we are interested in the shape and structure 
of a protein that is sometimes the root cause of Parkinson’s Disease. We use a variety of 
scientific techniques to figure out essential information of our protein of interest, which could 
provide an avenue for the development of therapies used to treat patients that are diagnosed 
with Parkinson’s Disease. 
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Chapter 1  
1 Introduction 
1.1 Parkinson’s Disease  
The past half-century has seen a dramatic increase in life expectancy; global life 
expectancy has changed from 52 years of age in 1960 in comparison to today’s 72 years of 
age (World Bank Stats). While this can be attributed to medical advancements and 
increased standard of living, living longer is ironically accompanied by an assortment of 
age-related diseases. Such diseases include Parkinson’s disease (PD), Alzheimer’s disease, 
Huntington’s disease, Amyotrophic Lateral Sclerosis (ALS), chronic obstructive 
pulmonary disease (COPD) and multiple forms of cancer, which cover a wide array of 
symptoms (1). A common factor of age-related diseases is the progressive deterioration of 
tissue maintenance and cellular homeostasis, leading to the development of degenerative 
diseases. In particular, Parkinson’s disease is a neurodegenerative disorder of the central 
nervous system, characterized by the deterioration of dopaminergic neurons of the 
substantia nigra pars compacta (SNpc). James Parkinson, a British physician, first 
characterized the symptoms of PD in his 1817 essay and dubbed the disease the “Shaking 
Palsy”. Parkinson’s essay depicted the lives of several patients, where he documented the 
classic features of PD, including tremors, an abnormal posture and gait, and muscle 
weakness, as well as the progressive nature of the disease (2). Jean-Martin Charcot would 
go on to further characterize the disease, distinguishing PD from other tremor-related 
diseases such as multiple sclerosis, establishing distinctions between symptoms including 
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rigidity, weakness and bradykinesia, and would finally name the disease after its 
discoverer, Parkinson’s Disease.  
 Progress in understanding Parkinson’s Disease was meagre until nearly a century 
later. The combined efforts of Georges Marinesco, Edouard Brissaud, Jean-Baptiste 
Charcot and Paul Oscar Blocq would establish a possible link between substantia nigral 
impairment with PD symptoms. Their discovery was attributed to a patient presenting with 
symptoms of a unilateral PD, where after his death a tumor was found primarily impacting 
the contralateral substantia nigra (SN)(3). A fortunate discovery, at a time where little 
attention was paid to the SN and other brain structures were of major focus. The collective 
efforts of these four researchers would be validated by Konstantin Nikolaevich Trétiakoff, 
in Marinesco’s own lab, whose work cemented the idea that the loss of SN neurons gave 
way to the development of Parkinson’s Disease (4). The name substantia nigra is Latin for 
“black substance”, which is reflective of the structure’s increased neuromelanin levels due 
to its density of dopaminergic neurons that stain and appear darker than neighboring 
structures. The implication of dopaminergic neurons in PD would eventually lead to one 
of the most crucial discoveries in Parkinson’s disease treatments, levodopa therapy (5). 
While studies of Parkinson’s disease thus far dwelled on the pathophysiology of 
the disease, one of the first biochemical links was discovered by Oleh Hornykiewicz. His 
research established autopsy evidence of diminished levels of dopamine levels in striatum 
of PD patients in 1960 (6). Hornykiewicz would later establish correlations between 
decreasing levels of dopamine with increasing severity of PD like symptom, until finally 
his work with his colleague Walther Birkmayer in 1961, where they conducted clinical 
tests with levodopa (L-dopa), a dopamine analog (7). Their studies revealed L-dopa to be 
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a sufficient analog and an effective treatment in alleviating Parkinson’s disease symptoms 
in 20 PD patients. These results were the first piece of biochemical evidence between 
dopamine and neurodegeneration, and with a long-lasting impact; L-dopa remains the most 
effective drug for treatment of PD today, over 50 years after its discovery (8). 
Lewy bodies (LB) were first discovered by Fritz Heinrich Lewy in 1910, who noted 
unusual inclusion in the brains of patients who had neurological deficits, causing 
behavioral changes in both speech and motion (9). Their relevance to PD came almost a 
decade later in 1919, when Konstantin Nikolaevich Trétiakoff would establish a 
relationship between the presence of LB’s in the SN and the development of PD (4). Lewy 
bodies are proteinaceous inclusion bodies which are recognized as the histological 
hallmark of PD. Although LB’s remain one of the major factors in the diagnosis of PD, 
they remain an enigma in terms of their role in the development of PD, and further research 
may provide a potential therapeutic target. 
Parkinson’s disease research may still be considered in its youth; while many 
breakthroughs have come about since its first description back in 1817, little headway has 
been made in the disease’s genetic cause and effects. This is unsurprising, given that 
sporadic cases account for over 95% of all PD cases. The first genetic description of PD 
came just over 20 years ago, where a missense mutation in the long arm of chromosome 4 
was documented in a family that was genetically predisposed to developing PD (10). This 
mutation would present itself in the protein α-synuclein (SNCA), which would later be 
implicated as the major component of Lewy Body formation and would have a monogenic 
autosomal dominant phenotype. Mutations in SNCA are responsible for a severe form of 
L-dopa responsive early-onset parkinsonism. This distinction created a need for a system 
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of classifying PD due to the heterogenicity of genetic predispositions causing different 
variations of PD. The discovery of SNCA would subsequently drive an abundance of 
research in genetic cell and animal modeling of PD (11–13), leading to the discovery of 
numerous other PD-related genes. While a total of 23 loci and 19 causative genes have 
been identified, these genes vary greatly with regards to phenotype (PD only or PD plus 
syndromes), age-at-onset (juvenile or adult onset), and inheritance mode (autosomal 
dominant, recessive or X-linked) (14). Of these genes, PARK2 has garnered much focus. 
The gene is implicated in the development of a recessive, early-onset form of PD and 
encodes for parkin, an E3 ubiquitin ligase (15, 16). The ligase activity is essential in 
modulating the ubiquitin-proteasome system and is responsible for the breakdown of 
mitochondrial proteins. Parkin will be the main focus of this thesis. 
 
1.2 Mitochondrial impairment in Parkinson’s Disease 
Advances in our knowledge of mitochondrial interactions and their role in cellular 
metabolism have contributed to a major progression in our understanding of many 
neurodegenerative diseases. Emerging evidence has linked cellular and genetic 
mitochondrial impairment to the onset of PD. Impaired mitochondrial function has become 
an underlying factor in a majority of neurodegenerative disorders, which is unsurprising 
given the fact that neurons have high energetic demands, thus necessitating a high 
concentration of mitochondria, and that nerves lack the ability to regenerate (17).  
A major breakthrough in linking Parkinson’s disease and mitochondrial impairment 
occurred in 1976 as a result of an accident involving a 23-year-old chemistry grad student, 
Barry Kidston. Kidston was chemically synthesizing recreational drugs and inadvertently 
 
5 
 
created a toxic side product, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (18). 
Within 3 days, Kidston would end up developing symptoms consistent with PD, which 
were responsive to L-dopa treatment. After his death, an autopsy revealed several classical 
indicators of PD, including deterioration of SNpc dopaminergic neurons, decreased levels 
of cerebrospinal fluid (CSF) dopamine levels and the presence of LB’s within the SNpc 
(19). This striking and almost instantaneous effect was later found to be caused by the 
metabolism and selective destruction of neurons within the SN. MPTP is lipid soluble and 
capable of crossing the blood-brain barrier, where it is metabolized by monoamine oxidase-
B (MAOB) in a two-step pathway into 1-methyl-4-phenylpyridinium (MPP+), a potent 
neurotoxin (Figure 1.1) (20). This toxin then accumulates within dopaminergic neurons 
where it interferes with Complex I of the electron transport chain (ETC). This eventually 
leads to inhibition of ATP production and stimulates superoxide radical formation, which 
then subsequently leads to increased levels of reactive oxygen species (ROS) and 
dopaminergic cell death (4). Kidston would soon be followed by six more similar cases, all 
of whom had fallen victim to the same drug (22). MPTP not only highlighted respiratory 
chain dysfunction and mitochondrial impairment as integral to the pathogenesis of PD, 
researchers also saw the prospective value of MPTP as a highly selective chemical to study 
nigrostriatal degeneration and the potential to induce PD in animals. 
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Figure 1.1 Chemical structures of MPTP and its metabolic derivatives. 
MPTP, a toxic by-product of opioid synthesis is converted to MPP+ via a two-step reaction. MPP+ is 
neurotoxic and is capable to diffusing into the substantia nigra and selectively destroy dopaminergic 
neurons. 
 
 
Mitochondrial involvement in PD has been confirmed through the discovery of 
several PD-related genes. Of the first genes implicated was α-synuclein. While its exact 
function has yet to be elucidated, overexpression of wild-type SNCA, or introduction of 
Ala53Thr, Glu46Lys of His50Gln mutants have been shown to induce mitochondrial 
fragmentation and subsequent increase in ROS levels (23). SNCA was also shown to be 
associated with mitochondria-associated membranes (MAM), creating an interface 
between the endoplasmic reticulum (ER) and mitochondria for the purpose of Ca2+ 
signalling and apoptosis (24). DJ-1 is another protein with an unclear function, and is 
related to the onset of recessive PD. However, deletion of DJ-1 has been shown to cause 
similar disruptions to mitochondrial membrane potential and fragmentation pattern, which 
is rescuable with the administration of glutathione as a ROS scavenging system (25). 
Alternatively, the PINK1/parkin pathway is an example of two PD-related proteins that 
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have well defined functions within a mitochondrial degradation pathway. As oxidative 
stress disrupts the mitochondrial membrane potential, it allows stabilization of PTEN 
induced Kinase 1 (PINK1) in the outer mitochondrial membrane (OMM), which can 
subsequently recruit and activate parkin on the mitochondrial periphery via its kinase 
activity. Parkin then exerts its ubiquitination activity on a host of OMM and associated 
proteins, thus targeting the mitochondria for degradation via mitophagy (26). In addition 
to this pathway, both PINK1 and parkin also exhibit supplementary functions that are 
involved in mitochondrial physiology. PINK1 is required for phosphorylation of Ser250 of 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10 (NDUFA10), which 
is essential for the reduction of ubiquinone in the ETC (27), while parkin has been shown 
to interact with mitochondrial Stomatin-like protein 2 (SLP-2), which functions in the 
assembly of respiratory chain proteins (28). Clearly, the onset of Parkinson’s disease is 
very closely intertwined with mitochondrial health.  
 
1.3 Reactive Oxygen Species and Oxidative Stress 
Mitochondrial dysfunction is a hallmark of PD and inevitably leads to a disruption to the 
delicate balance of the free radical equilibrium in cells. Free radicals, including ROS and 
reactive nitrogen species (RNS), are a class of highly reactive molecules and are derived 
from molecular oxygen or nitrogen, respectively. These include superoxides, peroxides, 
hydroxides, hydroxyl radicals, and nitric oxide (NO). ROS can originate from both 
endogenous sources (mitochondria, peroxisomes, ER, phagocytic cells etc.) and exogenous 
sources (pollution, alcohol, tobacco smoke, heavy metals, transition metals and radiation) 
(29). Oxidative stress is defined as the state in which the rate of ROS production exceeds 
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the rate of ROS clearance. The generation of free radicals occurs as a by-product of natural 
cellular metabolism. A free radical is defined as an atom or molecule that contains one or 
more unpaired electrons in its valence shell. These radicals are highly reactive and short-
lived; they are capable of attacking other molecules by scavenging an electron in order to 
stabilize themselves. Increased levels of free radicals can have extensive consequences 
throughout the cell, damaging a variety of macromolecules such as DNA, RNA lipids and 
proteins. However, the levels of free radicals in cells must be delicately maintained, as 
moderate levels of ROS/RNS have been shown to be beneficial, functioning in various 
physiological functions, such as the immune system, as well as in signal transduction for 
the purpose of cell proliferation, differentiation, and migration (30, 31).  
The majority of cellular ROS is produced by the mitochondrion, at the site of 
oxidative phosphorylation. Two components of the electron transport chain (ETC) are 
responsible for superoxide radical formation: complex I (NADH dehydrogenase) and 
complex III (ubiquinone cytochrome c reductase). In normal ETC function, complex I and 
III utilize ubiquinone (Q), while complex I also uses flavin mononucleotide (FMN) as 
cofactors in electron transfer. Complex I transfers two electrons from a reduced 
nicotinamide adenine dehydrogenase (NADH) via FMN and seven FeS clusters onto 
ubiquinone, generating reduced forms of FMN (FMNH2) and ubiquinone (QH2),  in order 
to generate a proton gradient to generate adenosine triphosphate (ATP) via oxidative 
phosphorylation (32, 33). In this process, free radicals of FMN (FMNH*) and Q (QH*) are 
generated. At complex I, two possible situations can occur that lead to the generation of 
ROS; an excess of NADH creates a backup of electrons on FMN and the FeS clusters, or 
through a process of reverse electron transfer (RET) in which electrons flow retroactively 
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from complex II back to complex I via ubiquinone. Meanwhile, complex III catalyzes the 
oxidation of QH2 to Q, and at this juncture, the free radical QH* is formed (34). An excess 
of either (FMNH*) and (QH*) will spontaneously donate an electron to molecular oxygen 
(O2), generating the superoxide free radical (O2-). As this process is non-enzymatic, the 
rate is simply second order and is entirely dependent on the concentration of the free 
radicals FMNH* and QH* and the availability of O2 (32).  
The superoxide anion is the consider the progenitor of most reactive oxygen species 
in cells, breaking down and interconverting into a majority of the ROS species present 
within cells. The majority of superoxide is produced in the mitochondria, and to a much 
lower extent within the cytosol, which is rapidly dismutated by mitochondrial superoxide 
dismutase (MnSOD or SOD2) or by cytosolic superoxide dismutase (Cu-ZnSod or SOD1). 
The enzymatic activity of SOD enzymes is considered to be ROS scavenging, as part of 
the cell’s mechanism to combat increasing levels of ROS. The products of superoxide 
dismutation are hydrogen peroxide (H2O2) and O2. While hydrogen peroxide is not 
considered a free radical, H2O2 has been shown to cause ROS-mediated cell damage at 
concentrations as low as 10 µM, while concentrations greater than 50 µM have been shown 
to be cytotoxic to a variety of animal, plant and bacterial cells. Physiological steady-state 
concentrations of H2O2  are maintained between 1-10 nM, while an increase in beyond 
these levels is considered oxidative stress and can lead to a variety of pathologies, including 
PD. H2O2 toxicity is mediated by the activity of catalase, which catalyzes the breakdown 
of H2O2 to water and oxygen (27). H2O2 itself has been shown to be poorly reactive, and 
does not readily react with most lipids, DNA or protein (26). H2O2 in cells has demonstrated 
an important role in cellular signalling pathways such as regulating transcription, altering 
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cell morphology, initiating cell proliferation and recruitment of immune cells. H2O2 acts as 
a messenger through the oxidation of thiol and metal centers; it can upregulate bacterial 
ROS scavenging genes (35), modulate protein phosphatase activity (36). H2O2 can function 
as more than just a damage signalling molecule which is becoming increasingly 
recognized. The most dangerous and harmful ROS species, however, is the hydroxyl 
radical (•OH). The formation of the hydroxyl radical can occur in two ways: superoxide 
degradation via the iron catalyzed Haber-Weiss reaction, or spontaneous conversion of 
H2O2 exposed to UV light (Figure 1.2) (28). It is notable that the second step of the Haber-
Weiss reaction is the Fenton Reaction, which involves the oxidation of a ferrous ion (Fe2+) 
to a ferric ion (Fe3+), and in the process decomposing a hydrogen peroxide molecule into a 
hydroxyl radical and a hydroxide ion (29). 
 First step Fe3+ + •O2− → Fe2+ + O2 
Fenton Reaction (2nd Step) Fe2+ + H2O2 → Fe3+ + OH− + •OH 
 Haber Weiss Net Reaction •O2− + H2O2 → •OH + OH− + O2 
Figure 1.2. Haber Weiss net reaction and reaction steps. 
The Haber Weiss reaction is a two-step reaction that converts superoxide to a hydroxyl 
radical. The second step of the Haber Weiss reaction is additionally known as the Fenton 
reaction, which can occur independently and convert hydrogen peroxide to a hydroxyl 
radical. 
 
While most ROS are capable of reacting with biological molecules to some degree, 
the hydroxyl radical is capable of reacting with virtually all types of biological molecules 
and some inorganic molecules as well. The hydroxyl ion has an enormous oxidizing 
potential and a half-life of 10-9 seconds, making it an extremely harmful species in vivo 
(37). The hydroxyl radical is capable of modifying components of DNA such as the 
deoxyribose sugar backbone, purine and pyrimidine bases, and induce single and double 
stranded breaks. As ROS concentrations are typically higher in the mitochondria in 
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comparison to the nucleus, mitochondrial DNA (mtDNA) has been shown to exhibit higher 
levels of oxidative damage. Indeed, the hydroxyl radical has been shown to create adducts 
or crosslinks on every DNA/RNA base pair (38), for example, levels of 8-hydroxy 
deoxyguanosine (8-OHdG), which is considered as the biomarker of oxidative DNA 
damage, is markedly higher in mtDNA as opposed to nuclear DNA, and has been shown 
to be implicated in mutagenesis, carcinogenesis and ageing (39). The hydroxyl radical is 
also capable of oxidizing lipids, especially polyunsaturated fatty acid residues of 
phospholipids. Lipid oxidation has been shown to hamper membrane function causing 
decreased fluidity, inactivation of membrane bound enzymes and receptors (40). 
 Proteins and other amino acid based molecules have been shown to be chemically 
modified by superoxide, hydroxyl radical and hydrogen peroxide, among many other 
ROS/RNS species (41). ROS are capable of oxidizing residues such as tryptophan, 
phenylalanine, tyrosine, histidine, asparagine, aspartic acid, lysine, proline, threonine, 
leucine and valine (42), resulting in the denaturation and loss of functioning of proteins, 
abolishing enzymatic, transport and receptor activities.  The sulfur containing amino acids, 
methionine and cysteine, are particularly susceptible to oxidation by ROS and are 
converted to methionine sulfoxide and disulfide linkages, respectively. (43, 44). However, 
these residues are also readily converted back to their native forms by methionine sulfoxide 
reductases and disulfide reductases, respectively (45). Cysteine is particularly capable of 
being extensively oxidized to a variety of forms, include disulfides, sulfinic, sulfenic and 
sulfonic acids. However, only the native sulfhydryl, the disulfide and sulfenic acid forms 
are readily interconverted; oxidation beyond this level is not reversible (Figure 1.3) (45). 
The mechanism of oxidation is initiated by the deprotonation of the reacting thiol group, 
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and the formation of the thiolate ion. As the pKa of cysteine, 8.5, is well above cellular pH 
levels, only a small proportion is cysteine residues would be in the thiolate form at any one 
time. The thiolate ion is capable of the nucleophilic attack on an oxygen atom of hydrogen 
peroxide, and thus eliminated a hydroxide ion as a leaving group. This sulfenic acid is 
similarly subject to nucleophilic attack by another thiolate ion, again eliminating a 
hydroxide ion and forming a disulfide As ROS chemical modifications are quite extensive 
and affect almost all relevant biological molecules, it is expected that they are ubiquitous 
in the development of a wide array of disease. Increased ROS and oxidized product levels 
have been implicated in several types of cancer, cardiovascular disease (CVD) (46) and 
atherosclerosis (47). ROS-mediated damage is especially prevalent in neurodegenerative 
diseases, as the CNS contains high lipid content and a higher metabolic rate due to a high 
density of mitochondria.  
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Figure 1.3. Oxidation schematics of cysteine oxidation. 
Cysteine is readily converted between the sulfhydryl, disulfide and sulfenic acid forms. Increasing levels 
of oxidation can convert cysteine to the sulfinic and sulfonic acid forms (A). Reaction mechanism showing 
the interconversion between sulfhydryl, sulfenic and disulfide forms (B) 
 
Oxidative stress has a complex role in the development of PD as cascading, self-
propagating mechanism, which in turn may be insightful to the progressive nature of the 
disease. Oxidative modifications of SNCA has been shown to promote tyrosine cross-
linking, which in turn causes toxic soluble oligomers that may be precursors to LB’s (48). 
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As PD is intrinsically tied to the degradation of dopaminergic neurons, dopamine itself 
becomes a reactive oxygen species. Indeed, as onset of PD begins with neuronal 
deterioration, levels of monoamine oxidase B (MAOB) begin to increase. MAOB 
metabolises dopamine into H2O2, which is highly membrane permeable, where it can 
diffuse to neighboring dopaminergic neurons and undergo the Fenton reaction to form 
hydroxyl radicals, thus propagating ROS mediated damage and further amplifying it (49).  
 
1.4 Parkin 
Ubiquitination is a complex signaling pathway where linkage types and substrates can lead 
to a variety of molecular fates. The ubiquitination pathway is mediated by an enzymatic 
cascade consisting of an E1 activating enzyme, E2 conjugating enzyme and finally an E3 
ubiquitin-ligating enzyme, which will catalyze the transfer of ubiquitin to the final 
substrate. Parkin preferentially ubiquitinates mitochondrial membrane proteins when 
mitochondria become depolarized—a signal of mitochondrial damage.  
Parkin belongs to the RING-BetweenRING-RING (RBR) subclass of E3 ubiquitin 
ligases. RBR ligases are distinct from other simpler E3 ligases as they display a higher 
level of structural complexity, as all RBR’s can be characterized as multidomain proteins 
(Figure 1.4). Parkin itself consists of five domains: an N-terminal ubiquitin-like (Ubl) 
domain, a RING0 domain, a RING1, a BRcat (benign-required for catalysis) domain and 
Rcat (required for catalysis) domain, with the latter three domains comprising the hallmark 
RBR sequence (50). RING domains typically have a distinct structural arrangement, where 
2 Zn2+ ions are coordinated in a cross-brace fashion (51). While the BRcat and Rcat were 
previously assumed to be canonical RING domains, more recent research has deemed them 
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as non-canonical RING domains, necessitating the need for contemporary nomenclature 
used in this work. RING0, RING1, BRcat and Rcat have a structural commonality in their 
Zn2+ coordinating abilities; using a combination cysteine and histidine residues, each 
domain coordinates two Zn2+, for a total of eight (52). However, RING1 is the only true 
RING domain; RING0 binds two Zn2+ ions in a hairpin arrangement unique to parkin, 
while the BRcat and Rcat domains show a sequential arrangement of Zn2+ -coordinating 
residues (53). Parkin also contains an impressive proportion of cysteine residues, totalling 
35 cysteines which make up 7.5% of the entire protein, in comparison to the human 
proteome average of 2.3% (54).The Ubl domain is shared with only one other RBR E3, 
heme-oxidized IRP2 ubiquitin ligase-1 (HOIL-1), however its function as an 
intramolecular inhibition module is unique to parkin (55). The Ubl domain binds the 
RING1 domain to negatively regulate parkin ubiquitination activity, by obstructing the site 
required for E2 recruitment and preventing the transfer of ubiquitin (56, 57). The Ubl is 
sequentially tethered to RING0 by an extensive linker (residues 77-140) of unknown 
function. Deletion of the Ubl and incremental N-terminal deletion of the linker causes 
upregulation of parkin activity, however, complete elimination of the Ubl domain and 
linker abolishes parkin activity (58).  
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Figure 1.4 Parkin structures and domain map. 
Parkin crystal structure from PDB code: 5C1Z. Parkin domains colored and labelled (A). Parkin’s 
cysteines are highlighted in red (B) and coordinated zinc ions are indicated by grey spheres. Parkin domain 
map (C) showing all cysteine residues in parkin. Cysteines mutated in PD are indicated by an asterisk (*) 
and the catalytic cysteine is indicated by two asterisks (**). Pathologic mutations were taken from Uniprot 
code O60260. 
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In healthy cells, parkin exists in its native, inactive state and is autoinhibited by the 
N-terminal Ubl domain. Parkin activation involves dual phosphorylation events by PINK1: 
phosphorylation of parkin on Ser-65 in addition to phosphorylation and subsequent binding 
of Ser-65 phosphorylated ubiquitin (pUb). Both events are required to facilitate the release 
of the autoinhibitory Ubl domain and fully activate parkin. However, PINK1 is 
constitutively expressed and then degraded by presenilin associated, rhomboid-like 
(PARL) protease (59). As a result of mitochondrial damage, there is a decrease in the 
mitochondrial membrane potential, otherwise known as mitochondrial depolarization, at 
which point ATP synthesis can no longer occur and mitophagy signaling is initiated (60). 
As Figure 1.5 demonstrates, mitochondrial depolarization leads to the inactivation of 
PARL, which thus allows the retrograde translocation and stabilization of PINK1 in the 
OMM, occurring concurrently with the increase in ROS levels. (61, 62). This allows 
PINK1 to phosphorylate OMM proteins that have been previously ubiquitinated, such as 
mitofusin and mitoNEET (63); these pUb-attached mitochondrial membrane proteins are 
believed to facilitate the selective recruitment of parkin to the periphery of the 
mitochondria, while binding of pUb, coupled with PINK1 phosphorylation stimulates 
parkin activity.  
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Figure 1.5 Overview of PINK1/Parkin mediated mitophagy. 
In healthy mitochondria, PARL constitutively cleaves PINK1, thus supressing it (left). When mitochondria 
are damaged, PARL is inhibited, allowing for the stabilization of PINK1, which can phosphorylate Parkin 
and ubiquitin, initiating and amplifying the signalling pathway for mitophagy. 
 
 
 Previous studies have analyzed parkin in the context of oxidative stress. As parkin 
has been found to be upregulated in an in vitro cell based PD model after MPTP-induced 
oxidative stress and also showed extensive cysteine modifications (64). Interestingly, 
another group demonstrated the formation of parkin dimers as a result of oxidation that 
were reversible under reducing conditions, suggesting the possibility of intermolecular 
disulfide linkage formation. This group also posited that parkin has potential as a ROS 
scavenger when compared maltose binding protein and SNCA (65, 66). Overall, the 
evidence shows that parkin may possibly be an oxidation-tolerant molecule and is capable 
of fulfilling a secondary function as a ROS scavenger after extensive exposure to oxidizing 
conditions. 
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1.5 Scope of Thesis 
Today we realize that PD is a complex and progressive disorder with an array of genetic or 
environmental causes that begin long before the disease is able to be clinically diagnosed. 
Current literature has extensively linked the role of mitochondrial dysfunction to the onset 
of PD. Parkin is an E3 ubiquitin ligase that belongs to a class of RBR ligases that are 
structurally defined by 3 RING-like Zn2+-binding motifs. Parkin is able to coordinate a 
total of eight Zn2+ ions via cysteine and histidine coordination. Indeed, parkin contains a 
total of 35 cysteine residues, 30 of which participate in Zn2+ coordination, and are essential 
for the structure and function. The function of parkin involves the ubiquitination of 
mitochondrial membrane protein to initiate the signalling of mitochondrial degradation, 
and the loss of this function has been shown to be implicated in the onset of recessive PD. 
As mitochondrial dysfunction is a signal for parkin recruitment and activation, which is 
concurrent with oxidative stress and an increase of ROS levels, parkin exposure to 
oxidative modification is inevitable, and its high proportion of oxidation-prone cysteine 
residues could indicate a valuable interaction in the pathogenesis of PD.  
Exposure of parkin to oxidation has only been examined at superficially as of recent. 
While studies thus far established a correlation in oxidative stress upregulating parkin 
activity, only a few studies have analyzed the direct impact of oxidative modifications on 
the function of parkin. One study of oxidative stress in the context of parkin, exposed 
parkin-overexpressing SH-SY5Ycells to H2O2 and observed an increase in ubiquitination 
activity after 2 hours, followed by a decrease in activity after 6 hours (64). The study 
rationalized this effect as immediate activation of the parkin pathway however, oxidative 
modifications abolished protein function. They also identified the peptides harboring 
 
20 
 
oxidative modification, identifying oxidation throughout the entire RBR domain, which is 
consistent with cysteine modifications, such as Cys431Phe and Cys441Arg, which are 
shown to be genetic mutations responsible for PD development.  
In this study, I establish a comprehensive analysis of parkin behaviour as a result of 
oxidative stress. The structural alterations of parkin are analyzed using SDS-PAGE and 
SDD-AGE in order to observe whether oxidation can influence parkin’s migration rates on 
gel-based assays. We also look to identify the possible products of oxidation with special 
focus on cysteine thiochemistry, which is capable of forming a multitude of products 
depending on the severity of oxidation. Mass spectrometry was used to identify which 
cysteine residues are more susceptible to protein oxidation, and to see if they are consistent 
with PD related gene mutations or are essential for protein function. We also examine the 
possibility of a novel function of parkin as a redox molecule. By conducting a parkin 
activity assay under oxidizing conditions, we hope to demonstrate oxidation-mediated 
abolishment of function. We will also examine the efficacy of parkin as a ROS scavenger 
by measuring its clearance rates of H2O2. As Parkin also uniquely coordinates a large 
number of Zn2+ ions, it is also possible that upon oxidation, parkin loses its ability to retain 
its Zn2+, which can cause liberation of these ions and possible downstream Zn2+ signalling. 
The importance of our study is to examine possible novel functions of parkin. Due 
to parkin’s unique structural motifs, as well as the inevitable interaction between parkin 
and ROS produced in cells, it could well-suited to act as a redox molecule. Structural 
biochemical techniques were used to elucidate the consequences of protein oxidation, 
which may further allude to the activation of parkin or inactivation other proteins leading 
to the pathogenesis of PD. While the activity of parkin will be assayed under oxidizing 
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conditions, we hope to elucidate a novel mechanism parkin. The recruitment of parkin to 
the mitochondrial periphery combined with an elevated cysteine content make it an ideal 
ROS scavenger, and the likely subsequent loss of Zn2+ ions may act as a potential signalling 
pathway.  
The field of PD research has cemented the role of parkin as an E3 ubiquitin ligase 
that functions in mitochondrial maintenance in the central nervous system. However, the 
implication of a novel function will require considerable evidence in order to convince 
researchers within the field to accept such a fact. Overall, the analysis of the complex 
interplay of oxidative stress and parkin may exemplify an unexplored avenue of parkin 
research that may prove valuable in understand the development and pathogenesis of 
Parkinson’s Disease. We hope to open new doors with our research, uncovering a facet of 
PD research that can have widespread and impactful effect on parkin research. 
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Chapter 2  
2 Oxidation of Parkin 
2.1 Introduction  
As this study focuses on parkin’s structure and activity under oxidative stress, we prepared 
several different forms of parkin that would allow us to capture the different states of parkin 
activation that would be present in cells. Parkin’s function plays a role in mitochondrial 
maintenance and upkeep of cellular health. As an E3 ubiquitin ligase that specifically tags 
mitochondrial proteins, parkin initiates mitophagy on depolarized mitochondria, which 
signals mitochondrial damage (1). Parkin activation involves the action of the upstream 
PINK1, which is a protein kinase that is constitutively expressed in the outer mitochondrial 
membrane (OMM), however it is rapidly and constitutively degraded when the 
mitochondrion is healthy, and its membrane potential is maintained. PINK1 specifically 
phosphorylates Ser65 of parkin, as well as the analogous Ser65 of a ubiquitin molecule 
(pUb). Parkin phosphorylation and binding with pUb is required for the release of Ubl 
domain and full activation (2) the. We took advantage of a Pediculus humanus orthologue 
of PINK1 to prepare in vitro phosphorylated parkin and ubiquitin, which has been shown 
to retain specificity and is constitutively active as opposed to the natural repressed human 
PINK1 (3).  
Upon further scrutiny of parkin’s structure and function, several features stand out 
that may be suggestive of a novel protein function. As parkin is capable of coordinating 
eight Zn2+ ions, which are facilitated by the action of cysteine and histidine residues, a 
comparison of cysteine content reveals a massive disparity. Parkin contains an impressive 
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35 cysteine residues, which make up 7.5% of the entire protein, in comparison to the human 
proteomic average of 2.3% (4). Cysteine, along with methionine, are the only two sulfur 
containing residues, while cysteine has a much more reactive thiol group. The thiol group 
is especially prone to oxidation, and is capable of forming disulfide links. As recruitment 
of parkin to the periphery of dysfunctional mitochondria is an essential step in parkin 
activation, this increase the risk of exposure to reactive oxygen species, and thus oxidation. 
Previous research has revealed parkin exposure to oxidizing agents is capable forming a 
dimer and is able to acts as a potential redox molecule (5). Although parkin’s function has 
been well-established as an initiation signal for mitophagy (6), the localization of parkin 
combined with its high cysteine content leaves may make parkin well suited as a redox 
molecule. Therefore, our study aims to assess parkin’s behaviour at various levels of 
oxidation, and provide an extensive analysis and identify the products of oxidation. 
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2.2 Materials and Methods 
2.2.1 His6-SMT3/His-TEV Tagged proteins 
The human PARK2 gene was inserted into a pET-SUMO expression system vector 
(Invitrogen) containing an upstream His6-SMT3 affinity tag and transformed into an 
Escherichia coli BL21 (DE3) previously by our collaborator at the Walden Lab (University 
of Dundee). A parkin truncation (residues 141-465, 141C) was generated using the 
Phusion® Mutagenesis Kit (Finnzymes) as previously described (6). The RING2 domain 
of Drosophila melanogaster parkin (residues 415C, Rcat) was also inserted into a pET-
SUMO vector as described above. All constructs were grown at 37 °C in Luria Broth (LB) 
media (Fisher BioReagents) and were supplemented with 250 µM ZnCl2 at inoculation and 
at induction. Cells were induced at an optical density at 600 nm (OD600) of 0.6 with 25 
µM of isopropyl β-D-1-thiogalactopyranoside (IPTG) for full-length parkin, 0.1 mM for 
141C or 0.5 mM for Rcat, then cells were incubated overnight at 16 °C. Cells were 
harvested in T500 lysis buffer (50 mM Tris, 500 mM NaCl, 0.5 mM TCEP, 25 mM 
imidazole, pH 8.0) and lysed with an Avestin EmulsiFlex-C5 homogenizer (ATA 
Scientific) at 15,000 psi. Cell lysates were ultra-centrifuged at 41,000 rpm (124,000 x g) 
and the pelleted cellular debris was discarded. Proteins were purified by Ni2+ affinity using 
a HisTrap FF column on an AKTA FPLC (GE Healthcare). Proteins were bound and 
extensively washed with lysis buffer, then eluted with T200e elution buffer (50 mM 
tris(hydroxymethyl)aminomethane (Tris), 200 mM NaCl, 0.5 mM TCEP, 250 mM 
imidazole, pH 8.0). Proteins were concurrently incubated with 2.5 mg of His-Ulp1 per liter 
of growth and dialyzed into T200 wash buffer (50 mM Tris, 200 mM NaCl, 0.5 mM TCEP, 
pH 8.0). The cleavage product was then run through a second His-Trap FF column to 
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remove His6-Ulp1 and cleaved His6-SMT3, and the cleaved protein was collected in the 
flow-through. Purified protein samples were concentrated using Vivaspin protein 
concentrator spin columns (GE Healthcare) and were further purified using SuperDex75 
10/300 GL size exclusion columns (GE Healthcare). Sacchromyces cerevisiae ubiquitin 
was expressed as a His6-TEV fusion construct and purified in a similar manner to the His6-
SMT3 fusion proteins but the affinity tag was cleaved by tobacco etch virus protease 
(TEV). Protein concentrations were measured by absorbance at 280 nm with a DeNovix 
DS-11 FX+ Spectrophotometer.  
 
2.2.2 GST-PINK1 
Pediculus humanus PINK1 (128-C) construct was cloned into a pGEX-6P1 GST Fusion 
vector, transformed into BL21 (DE3) Codon+ RIL cell line by, and was obtained from, Dr. 
Helen Walden (University of Glasgow). Cells were grown in LB media at 37°C to an 
OD600 of 0.8. Cells were induced with the addition of 0.1 mM IPTG, then incubated 
overnight at 26°C. Cells were harvested and resuspended in PBS buffer (137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4). Cell suspensions were lysed as 
described above and the supernatant was purified using a GSTrap FF column (GE 
Healthcare), washing extensively with lysis buffer and eluted with freshly prepared PBS 
plus 10 mM reduced glutathione. Purified GST-PINK1 was extensively dialyzed against 
two changes of T200 buffer pH 10.0 to remove the bound glutathione, and then against 
T200 pH 8.0.  
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2.2.3 Preparation of Phosphorylated Parkin and Ubiquitin 
Purified GST-PINK1 was incubated with either full length parkin (1:2 ratio) or ubiquitin 
(1:10 ratio) and dialyzed against buffer containing 50 mM Tris, 1.0 mM DTT, 10 mM 
MgCl2 and 10 mM ATP (pH 7.5) at 25°C overnight. Protein phosphorylation was 
monitored to completion using a phosphorylation affinity reagent, Phos-Tag AAL™ 
(NARD Institute Ltd) SDS–PAGE. Phosphorylated species have their migration rates 
retarded by the Phos-tag reagent, manifesting as an upshifted band on SDS-PAGE. 
Following the reaction, GST-PINK1 was removed using a GSTrap FF column, collecting 
the flow-through fractions containing phosphorylated parkin or phosphorylated Ub. The 
phosphorylated proteins were further enriched using a SuperDex75 10/300 GL column (GE 
Healthcare) size exclusion chromatography. 
 
2.2.4 Oxidation  
Purified protein samples were reacted in buffer containing 50 mM HEPES, 50 mM NaCl 
pH 7.0. Protein samples were prepared at 15 µM (141C, parkin, phospho-parkin) or 30 µM 
(RCat) and were exposed to various concentrations of hydrogen peroxide (Sigma Aldrich) 
over the course of 1 or 2 hours. Reactions containing pUb were conducted using a 1:1 ratio 
of pUb:parkin construct. Samples were taken at selected time points, quenched with 5 mM 
ascorbic acid and sample buffer, then incubated at room temperature for 1 hour. Samples 
were loaded onto a 15% SDS-PAGE gel and stained with Coomassie Brilliant Blue R-250 
(Thermo Fisher Scientific). Gels were destained then imaged using a BioRad Gel Doc 
Imaging system.  
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2.2.5 Analysis of protein aggregates 
Protein samples were oxidized in a time course as described above. The semi denaturing 
detergent agarose gel electrophoresis (SDD-AGE) protocol was conducted as previously 
described with minor modifications (8). The agarose-based gel was used to due to its larger 
pore size which allows analysis of structurally heterogenous amyloidogenic proteins whose 
insolubility and size are difficult to analyze using conventional SDS-PAGE. Samples were 
then loaded onto a 1.8% agarose gel containing 1% SDS with running buffer containing 40 
mM Tris acetate, 10 mM ethylenediaminetetraacetic acid (EDTA) and 1% SDS. SDS-
soluble proteins from the agarose gel were then transferred to a PVDF membrane overnight 
using a Whatman TurboBlotter kit using Tris Buffered Saline (TBS; 10 mM Tris, 150 mM 
NaCl pH 7.0). Membranes were blocked with 5% skim milk powder in PBST (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 0.1% Tween, pH 7.4) for 1 hour 
with shaking then probed with a 1:10000 dilution parkin RING2 mouse antibodies (Cell 
Signalling) at 4°C on a rocker overnight. Membranes were then probed with Alexa 680 
labelled anti-mouse secondary antibodies at room temperature for one hour, then rinsed 
with PBST and visualized on a LiCor Odyssey imaging system. 
 
2.2.6 Identification of oxidized species 
Samples (parkin, phosphoparkin, 141C and Rcat) were oxidized at 1 mM H2O2 for 3 or 15 
minutes then quenched with ascorbic acid. Samples were then desalted using 500 µL Zeba 
Spin Desalting Column (Thermo Fisher Scientific) according to manufacturer’s protocol. 
Mass spectrometry was performed on a QTof Ulitma mass spectrometer (Waters) equipped 
with a Z-spray source and run in positive ion mode with an Agilent 1100 HPLC used for 
 
33 
 
flow injection. MassLynx 4.1 software was used for data acquisition and data were 
deconvoluted using MaxEnt1. 
 
2.2.7 Band densitometry and reaction modeling  
141C parkin was used as representative protein. Time course oxidation assays of 15 µΜ 
141C were conducted in 1, 5 and 10 mM H2O2 in the presence and absence of pUb and 
were analyzed with SDS-PAGE. Gels were stained with Coomassie Brilliant Blue R250 
band intensity of oxidized species over time. SDS imaged using BioRad Gel Doc and band 
intensity was measured using ImageLab software. Band intensities were normalized to the 
highest intensity protein band present on the gel and data were analyzed using Prism 
software.  
 
2.3 Results 
2.3.1 Purification of parkin proteins 
For the experiments outlined in this study, recombinant parkin had to be expressed and 
modified to mimic the different states associated with parkin activity: full-length human 
parkin (1-465), an N-terminally truncated form, 141C (141-465), and D. melanogaster 
RCat, as previously described and displayed in Figure 1.4C. As previously shown (9), 
untagged parkin expressed poorly and was highly insoluble, while His- or GST tagged 
parkin yielded a purified protein product that showed degradation and was of poor quality. 
Parkin expression benefitted greatly from the addition of the His-SMT3 affinity tag and 
remained soluble even after cleavage (7). All proteins were soluble in LB media 
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supplemented with 0.5 mM ZnCl2, and protein expression was induced only after cells had 
been cooled to 16°C (Figure 2.1). Full-length His-SMT3 parkin was purified using a Ni2+ 
NTA affinity column, however the first elution was very impure, showing multiple bands 
from 11 kDa and well beyond the limits of the molecular weight ladder. This protein 
mixture after cleavage with Ulp1 showed some uncleaved protein, however the majority 
of the protein was able to be cleaved (Figure 2.1A). The protein mixture showed several 
contaminants that were retained after a second Ni2+ NTA affinity column, yielding purified 
full-length parkin band that ran at the expected 52 kDa, with some light contamination with 
lower molecular weight species in the 11-17 kDa range (Fig 2.1A). 141C and Rcat were 
purified in a similar manner, however both proteins had markedly less contamination in 
their initial elutions. Both proteins showed a larger proportion of Ulp1 cleavage (Figure 
2.1B-C).  
 After a second Ni2+ NTA affinity column, both proteins were comparatively pure, with 
very minor contamination in either case. All the above constructs were purified to 
homogeneity using size exclusion chromatography as a final purification step prior to all  
experiments. 
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Figure 2.1. Purification of His6-tagged Parkin and ubiquitin constructs. 
SDS-PAGE gels showing purifications of His6-tagged recombinant proteins used in this study. Parkin (A), 
141C (B) and Rcat (C) were expressed as His6-SMT3 constructs, while ubiquitin (D) was expressed as a 
His6-TEV construct. Flowthrough 2 indicated the final protein product to be used in further experiments, or 
were subject to size exclusion chromatography for further purification. 
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2.3.2 Purification of GST-PINK1 
PINK1 is a kinase for both parkin and ubiquitin and plays an essential role in parkin 
activation in cells (Figure 2.2). P. humanus PINK1 has been shown to reliably 
phosphorylate parkin and ubiquitin and is essential for in vitro preparation of different 
forms of parkin. PINK1 remained soluble in LB media growth and induction at 26 °C. Cell 
pellets were suspended and lysed in PBS buffer and PINK1 was purified using a GST-
Trap. PINK1 was eluted using reduced glutathione, giving rise to a band at 75 kDa, 
however the sample had several other contaminants. PINK1 remains in solution despite 
extensive dialysis at pH 10, which is required to remove reduced glutathione, as well as 
into a Tris buffer at pH 8.0.  
 
2.3.3 PINK1 reliably phosphorylates parkin and ubiquitin  
An essential step in parkin activation involves two phosphorylation events: 
phosphorylation of parkin’s Ubl domain on S65 and the phosphorylation of ubiquitin on it 
analogous S65. However, human PINK1 is sub optimal in terms of kinase activity and is 
unreliable for preparative phosphorylation of parkin of PINK1. We instead used an insect 
orthologue, specifically P. humanus PINK1, that is constitutively active and provides a 
reliable method of parkin and ubiquitin phosphorylation (2, 3). Recombinant PINK1 was 
successfully expressed as a GST-fusion protein lacking the N-terminal mitochondrial 
targeting and transmembrane domains. Purified PINK1 was used to successfully 
phosphorylate both parkin and ubiquitin, which were monitored using Phos-Tag SDS-
PAGE (10, 11). Both parkin and ubiquitin exhibited complete phosphorylation (Figure 
2.2) as indicated by depletion of the faster migrating band of the unphosphorylated species 
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and subsequent formation of the impeded, phosphorylated species. Phosphorylated parkin 
(phospho-parkin) was further enriched using GST affinity chromatography to remove 
PINK1 and size exclusion chromatography to remove residual ATP. Phosphorylated 
ubiquitin (pUb) was also similarly enriched, however, GST affinity chromatography could 
be omitted as size exclusion chromatography was sufficient to resolve the substantial size 
difference between PINK1 and pUb.  
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Figure 2.2. PINK1 Purification and in vitro phosphorylation of parkin and ubiquitin. 
SDS-PAGE gels showing purifications of GST-tagged recombinant PINK1 (A). Ubiquitin (B) and parkin 
(C) in vitro phosphorylation by PINK1, then analyzed using SDS-PAGE with Phos-Tag AAL reagent. The 
presence of phosphate on ubiquitin and parkin retards migration rates by interacting with the Phos-Tag 
reagent. 
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2.3.4 Parkin oxidation forms multiple discrete species 
In order to identify how oxidation might alter the structure of parkin we exposed parkin to 
a broad range of hydrogen peroxide (H2O2) concentrations (0-10 mM) and monitored 
reactions over a 2-hour time period. We expect some obvious structural modifications to 
occur due to parkin containing such a high cysteine content combined with exposure to an 
oxidizing environment, which may be readily visualized by SDS-PAGE. After exposure to 
H2O2, residual H2O2 was quenched using ascorbic acid, rather than DTT or TCEP, which 
is able to reduce H2O2 while remaining non-reactive to the oxidized protein. The ascorbic 
acid was thus used to halt the oxidation process while preserving any oxidized states of 
parkin.  
 
2.3.4.1 Oxidation: Parkin 
In the absence of hydrogen peroxide, parkin runs at its expected 52 kDa size on non-
reducing SDS PAGE gels, which remains consistent at 37 °C (Figure 2.3A). Upon 
oxidation, a number of new bands appear that are dependent on the H2O2 concentration and 
reaction time. At the lowest H2O2 concentration tested (1 mM) parkin rapidly forms a lower 
molecular weight species that runs as a broader band of approximately 48 kDa on the gel, 
while in later timepoints a larger species of approximately 80 kDa starts to form, as well 
as some slightly larger molecular weight species begin to form (Figure 2.3A). At higher 
H2O2 concentrations (5 and 10 mM) this oxidation process is accelerated, revealing the 
transition of the dimeric species to even larger oligomers, as evidenced by a laddering 
pattern which spans all the way up to the well. These oligomers have some degree of 
solubility but eventually become too large to enter or migrate any discernable distance into 
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the gel. This process of oligomerization is occurring more quickly in higher concentrations 
of H2O2, which is suggestive of disulfide mediated intermolecular linkages as the 
mechanism of oligomer formation. The addition of TCEP after the reaction is able to 
recover parkin back to its un oxidized monomeric state, as evidenced by the band that runs 
similarly at 52 kDa. 
 
2.3.4.2 Oxidation of 141C 
Compared to parkin, the N-terminally truncated form 141C oxidized in a similar manner, 
initially forming a broader, faster migrating band at approximately 30 kDa. This species is 
eventually depleted as oxidation creates a ladder of higher molecular weight species. 
However, 141C and parkin differ in their rates of oxidation; while parkin maintains a strong 
monomeric band that can be observed throughout the entire reaction at 1 mM H2O2, 141C 
is almost completely absent by the 120-minute mark. These trends are similar across H2O2 
concentrations, 141C is only faintly observed at 10 and 5 minutes for 5 and 10 mM H2O2, 
respectively, while is maintained to a similar intensity at the 30- and 10-minute time points. 
Both the full length and truncated forms of parkin eventually proceed to insolubility with 
no detectable protein at that point. 
 
2.3.4.3 Oxidation Assay: Phosphorylation and addition of pUb 
As parkin, phosphoparkin and 141C have the capacity to bind pUb, all three 
proteins were oxidized in the presence of pUb in a 1:1 ratio (Figure 2.5, 2.6). In the 
presence of pUb, both parkin and phosphoparkin can be observed oxidizing at a slightly 
slower rate when exposed to 1 mM H2O2, as observed by the higher band intensity at 120 
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minutes, compared to when pUb is absent (Figure 2.6). Similarly, 141C oxidation is 
delayed in the presence of pUb at all levels of oxidation, with protein being comparably 
more observed at 90, 15, and 10 minutes at 1, 5 and 10 mM H2O2, respectively (Figure 
2.5). When comparing parkin and phosphoparkin oxidation rates in 1 mM H2O2, very little 
change occurs with the addition of phosphorylation. Both proteins exhibit similar rates of 
oligomerization, however, it is interesting that upon reduction with TCEP, phosphoparkin 
is able to be recovered to a higher degree as evidenced by the higher intensity of the 
monomeric band at 52 kDa after TCEP treatment. 
 
2.3.4.4 Oxidation of Rcat 
Rcat was oxidized in a similar manner to parkin at a wider range of H2O2 concentrations: 
0.5, 1, 2, 5, 10 and 20 mM (Figure 2.5). Rcat was more resistant to oxidation, differing 
from the more obvious changes that occurred in the full-length parkin at similar H2O2 
concentrations. Oxidation assays of Rcat revealed very little change at lower H2O2 
concentrations, showing only faint dimer bands until 2 hours at 2 mM H2O2, where higher 
molecular weight species can start to be observed. However, due to the smaller molecular 
weight of Rcat, oligomerization is much more apparent, and bands are much more 
distinguishable up to 6 units long (Figure 2.5).  
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Figure 2.3. Parkin oxidation time course assays.  
Parkin was oxidized at 0, 1, 5 and 10 mM H2O2 (as indicated) in a 50 mM HEPES, 50 mM NaCl pH 7.0 
buffer. Reactions were quenched with 20 mM ascorbic acid to extinguish remaining H2O2. Samples were 
run on 16.5% tris-tricine SDS-PAGE, stained with Coomassie Brilliant Blue and imaged using a BIORAD 
Gel Doc.  
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Figure 2.4. Rcat oxidation time course assays. 
Rcat was oxidized at 0.5 (A), 1 (B), 2 (C), 5 (D), 10 (E) and 20 (F) mM H2O2 in a 50 mM HEPES, 50 mM 
NaCl pH 7.0 buffer. Reactions were quenched with 20 mM ascorbic acid to deplete any remaining H2O2. 
Samples were run on 16.5% tris-tricine SDS-PAGE and stained with Coomassie Brilliant Blue and imaged 
using a BIORAD Gel Doc. 
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Figure 2.5. 141C oxidation time course assays with and without phosphorylated ubiquitin.  
141C was oxidized at 1, 5 and 10 mM (A-C) H2O2, and with phosphorylated ubiquitin in a 1:1 ratio (D-F) 
at the same concentrations in a 50 mM HEPES, 50 mM NaCl pH 7.0 buffer. Reactions were quenched 
with 20 mM ascorbic acid to deplete any remaining H2O2. Samples were run on 16.5% tris-tricine SDS-
PAGE and stained with Coomassie Brilliant Blue and imaged using a BIORAD Gel Doc. 
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Figure 2.6. Parkin and phosphoparkin oxidation assays 
Parkin (A) and phosphoparkin (C) were oxidized at 1mM H2O2 in the absence and in the presence 
phosphorylated ubiquitin in a 1:1 ratio (B and D respectively) in a 50 mM HEPES, 50 mM NaCl pH 7.0 
buffer. Reactions were quenched with 20 mM ascorbic acid to deplete any remaining H2O2. Samples were 
run on 16.5% tris-tricine SDS-PAGE and stained with Coomassie Brilliant Blue and imaged using a 
BIORAD Gel Doc. 
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2.3.5 Oxidation of parkin results in disulfide bridge formation 
While the oxidation assays suggested the presence of higher molecular oligomerization 
occurring as a result of oxidation, we used mass spectrometry to identify the products of 
the oxidative process. Mass spectrometry analysis of unmodified parkin shows a single 
signal at 51640.89 Da, corresponding to the theoretical mass of parkin (51640.893 Da) 
(Figure 2.7A). Upon a short period of oxidation, the parent mass of parkin is absent and 
replaced by a major signal at 51638.6 Da, and a minor peak at 103277.5 Da (Figure 2.7B). 
The major signal is consistent with the loss of two hydrogen atoms arising from the 
formation of an intramolecular disulfide linkage in parkin. This causes the protein to 
migrate faster on an SDS-PAGE gel, presumably due to its more compact nature. Similar 
observations have been made for phosphoparkin, 141C and D. melanogaster Rcat (Figures 
not shown). One difference is that lack of a dimeric species when phosphoparkin was 
oxidized. The minor signal in the oxidized parkin spectrum arises from loss of four 
hydrogens atoms and likely corresponds to a dimeric parkin species formed by at least one 
intermolecular disulfide linkage. No higher molecular weight species were identifiable by 
mass spectrometry beyond these molecular weight ranges. 
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Figure 2.7. Mass spectrometry analysis of parkin before and after oxidation. 
Deconvoluted spectra of parkin before exposure to H2O2 and after exposure to 5mM H2O2 for 3 minutes, 
then quenched with ascorbic acid. Mass spectral ranges analyzed were inclusive of monomeric and dimeric 
masses, as well as larger molecular weight species but no signal was detected. 
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2.3.6 Parkin forms large molecular weight polymers analogous to 
Huntington’s Disease proteins 
A Semi-Denaturing Detergent Agarose Gel Electrophoresis (SDD-AGE) approach was 
used to characterize the larger molecular weight species. SDD-AGE is an approach used 
for detection of protein polymers and aggregates that are stable in 1% SDS, unlike most 
protein complexes. This method has well established for characterizing protein aggregates 
well in excess of 1000 kDa that are too large to enter conventional SDS-PAGE. 
Specifically, SDD-AGE has previously been used to characterize the hallmark PolyQ 
protein aggregates seen in Huntington’s disease. To confirm the presence of larger 
molecular weight oligomers, parkin and 141C were oxidized in 1 or 5 mM H2O2 over a 2-
hour time course. Samples run on SDD-AGE were then transferred to a PVDF membrane 
using a downward capillary transfer blotting setup. Proteins were initially probed using 
RING2 specific antibodies, then were probed with secondary antibodies tagged with Alexa 
680 fluorophore. Analysis of signal intensity revealed a time dependent formation of large 
protein aggregates, showing a smear that is darkest at 10 minutes, then appears to lose 
intensity by 15 minutes and disappears at the 30-minute mark (Figure 2.8). These samples 
were run parallel to two Huntington’s Disease related PolyQ constructs: 25Q, which does 
not form any protein aggregates, and 72Q, a known protein aggregate. At time = 0 min, 
parkin runs as a monomeric band, however, the band starts to elongate almost immediately 
after oxidation. After 10 minutes, parkin achieves a protein smear that mirrors that of 72Q, 
but also runs the entire length between monomer and the well, which indicates a 
heterogenous mixture of polymer lengths. A similar result was found for 141C as well, 
with the exception that 141C oxidized more quickly in the 5 mM H2O2 treatment.  
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Figure 2.8. SDD-AGE monitored analysis of oxidized parkin constructs over 2-hour time courses. 
SDD-AGE analysis of parkin and 141C were oxidized at 1 and 5 mM H2O2 and time points were quenched 
with ascorbic acid. Gels were transferred to PVDF membrane and proteins were probed with RING2 
specific antibodies and Alexa 680 tagged secondary antibodies. Controls (top left, side set) include two 
Huntington’s disease implicated proteins, 25Q, which has been shown to not aggregate, and 72Q, which 
has been shown to aggregate. 
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2.3.7 Products of oxidation followed an ordered pathway 
To provide more insight into the actual formation of the oxidized species, band 
densitometry was used to measure formation of each discrete species. For this experiment, 
141C was used in lieu of parkin for band densitometry analysis. Both proteins show a very 
similar progression of oxidation, with the added benefit that 141C gels contained fewer 
contaminants, simplifying band densitometry measurements. We used the oxidation of 
141C at 5 mM H2O2 for our explanation (Figure 2.10B). We separated each lane into 
ranges surrounding discrete bands depending on migration distance, in which we measured 
Coomassie stain intensity. The largest raw intensity value was assigned a value of 1, and 
all other measurements were normalized to this value. Our initial material is presumably 
unoxidized monomer, while the downshifted band which forms immediately after adding 
H2O2 is presumably oxidized monomeric protein. Above the oxidized monomer is most 
likely oxidized dimer and all increasingly larger material was grouped as polymeric 
species. Following exposure to oxidation, the unoxidized monomer (red curve) 
downshifted immediately, giving rise to the broader, faster migrating band. The oxidized 
monomeric species (black curve) had the highest raw signal intensity, and after 
normalization, the initial material had an intensity of approximately 0.6. The oxidized 
material is most likely a heterogenous mixture of intramolecular disulfide bonds, which 
would have slightly different migration rates, causing the much broader band as a result of 
oxidation. The unoxidized material an expectedly more homogenous mixture which results 
in a thin and sharp band, which is limited in the amount of Coomassie stain uptake and 
therefore, results cannot be strictly quantitative. However, as a semi-quantitative method 
we still observed the almost instantaneous formation of the oxidized monomer which our 
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model shows should peak at a value beyond the limits of our graph, but tapers off 
throughout the rest of the reaction. The dimeric species (blue curve) is also shown to 
increase almost instantaneously, band densitometry shows a slower formation than the 
oxidized monomer. This species peaks at 0.3 at approximately 2 minutes, then tapers off 
and disappears. Subsequently, the polymeric species (green curve) have a delayed start of 
formation, and begins to increase at approximately 2 minutes, which is concurrent with the 
maximal peak intensity of the dimeric species. The polymeric species then peaks at 
approximately 3 minutes to a value of 0.7. It is interesting to note that in most conditions, 
the monomeric oxidized species persists longer than any of the higher order molecular 
weight species. We propose a potential pathway, as shown in Figure 2.9. A possible bottle 
neck occurs where the monomeric oxidized exists. 
 
 
 
 
 
 
Figure 2.9. Proposed reaction schematic of parkin oxidation. 
Parkin (as indicated by P) oxidation proceeds through a possible pathway, where the 
unoxidized, monomeric form of parkin is oxidized while remaining monomeric, then 
proceeds to form intermolecular disulfide bonds. These bonds forms dimers, then proceed 
to polymerize, forming subsequently larger molecular species until it eventually proceeds 
to insolubilization. 
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Figure 2.10. 141C oxidation time course plots. 
ImageJ was used to measure band density and plotted as relative abundance for each condition: 1mM 
(A), 5mM (B), and 10mM (C) for 141C alone and with phosphorylated ubiquitin (D,E,F). The species 
measured include unoxidized monomer (red), oxidized monomer (black), dimer (blue) and polymer 
(green). Data were analyzed using non-linear regression with a modified one phase decay models using 
Prism software. Error bars are derived from an n=3. 
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2.4 Discussion 
The current understanding of parkin’s function is that it plays a neuroprotective role in cells 
via its E3 ubiquitin ligase activity. Parkin is recruited to the periphery of dysfunctional 
mitochondria and targets them to the proteasome via ubiquitin-mediated degradation. 
Considering parkin’s localization and its above average cysteine content, it is not surprising 
that parkin is susceptible to oxidative modifications, and indeed has been shown to be 
oxidized in vivo. Therefore, we set out to examine parkin’s behavior under oxidizing 
conditions. 
The collection of proteins that were purified for the purposes of this study 
encompass a crucial step in parkin regulation and activation. In cells, parkin activity is 
closely linked to mitochondrial health, as depolarization of the mitochondrial membrane 
allows PINK1 stabilization on the OMM, where PINK1 can phosphorylate parkin and 
ubiquitin. Both events are required for release of the autoinhibitory Ubl domain, allowing 
parkin to adopt an extended, active conformation. While the exact mechanism of parkin 
recruitment and activation is still yet unknown, we are aware of possible parkin 
intermediates before it is fully activated. Unmodified, wild-type parkin is the inactivated 
form of parkin, while pUb-bound, phosphorylated parkin is the fully activated form, 
however the order of these events remains unclear. I prepared both phosphorylated parkin 
and phosphorylated ubiquitin to homogeneity, which allowed me to either recreate parkin 
activation in both scenarios, whether pUb binding occurs first or parkin phosphorylation 
does. Both parkin and phosphoparkin are capable of binding to pUb with high affinity, as 
they both elute in complex with pUb in the same fractions using size exclusion 
chromatography as previously shown (12).  
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Parkin was also expressed as two truncations, the human 141C and Rcat domain 
from D. melanogaster. The 141C, which acts as a pseudo-uninhibited form of parkin, 
construct lacks two consecutive domains: the autoinhibitory Ubl domain (1-76) and a 
disordered linker of unknown function (77-140). The Rcat domain, while functionally 
inoperable when isolated, contains parkin’s catalytic cysteine. Additionally, as a RING-
like domain, it is used as a representative of the full-length protein which contains 4 RING-
like domains that all coordinate 2 Zn2+, and its high solubility and exceptional expression 
levels provide a simple model that is easy to work with.  
It is important to note that while cellular levels of ROS are maintained between 10 
and 100 nM, we tested an array of H2O2 concentration that were much higher (0.5-20 mM) 
(Figures 2.3-2.6), because this was a more practical concentration to show parkin’s 
behavior as a result of oxidative stress. These results can be interpreted as an accelerated 
process that would occur, as opposed to the chronic exposure to low levels of H2O2, and 
possibly reflect the symptoms prevalent in PD patients. By initially exposing parkin to 
H2O2, we were able to observe an initial downshifting of parkin when analyzed on SDS-
PAGE (Figure 2.3). This increased migration rate is most likely due to intramolecular 
disulfide bridge formation, as identified by mass spectrometry by a mass loss of 2 Da, 
which is consistent with the loss of 2 hydrogen atoms (Figure 2.6). The downshifted band 
is much broader than the initial protein, which may be an indicator of disulfide bond 
heterogeneity. Parkin contains 35 cysteines residues, the majority of which participate in 
Zn2+ coordination, thus creating ample opportunities of closely associated cysteines that 
can participate in disulfide bond formation. This could give rise to a mixture of compacted 
protein molecules with slightly different migration rates. The reaction then proceeds to 
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form a larger dimeric species, which was observable by mass spectrometry, but at a very 
small intensity (Figure 2.6). Interestingly, the dimer was observable for parkin, 141C and 
Rcat, but not phosphoparkin. The degrees of mass losses were slightly varied across each 
construct. Parkin formed a dimer that was twice the mass of an unoxidized monomer less 
5.31 Da, corresponding to a loss of approximately 6 total hydrogen atoms. This would be 
consistent with a total of 2 intramolecular disulfide bonds and one intermolecular disulfide 
bond, however any possible arrangement of inter- and intramolecular bond formation could 
occur as long as one intermolecular disulfide bond existed. Interestingly, 141C exhibited 
much more extensive disulfide bond formation, as the dimer mass detected was 13.71 
Daltons lighter than the mass of 2 unoxidized monomers. This would correspond to a 
possible 7 total disulfide bonds formed, which may be due to more extensive solvent 
exposure as 141C lacks the Ubl domain and linker domains. These domains only contain 
only two cysteines but may protect cysteine residues within BRcat and RING1. 
Interestingly, oxidized Rcat formed a monomer with a mass loss of 1.14 Da, a dimer with 
a total mass loss of 2 Da, which corresponds to a single intermolecular bond. RCat does 
not form a dramatically downshifted band similar to full length and 141C parkin, which 
may be attributed to its smaller size and therefore migration rate is not dramatically altered 
by an intra molecular disulfide, or the RCat does not favorably form intramolecular 
disulfide bonds and instead preferentially forms intermolecular linkages instead.  
While analysis by mass spectrometry was limited to only detecting dimer formation 
as a result of oxidation, the data obtained validated the presence of intra- and intermolecular 
disulfide bond formation. However, SDS-PAGE analysis also showed higher order 
molecular weight species, and in order to characterize such high molecular weight species, 
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we used an SDD-AGE approach. Parkin and 141C exposure to oxidation formed polymers 
much more extensively than what could possibly be observed on SDS-PAGE. This process 
is accelerated as a result of higher H2O2 concentration, which is consistent with our finding 
from SDS-PAGE. As SDD-AGE is not a quantitative method, our loading controls 
included two Huntington’s disease-related PolyQ proteins. These proteins 25Q and 72Q 
are model poly-glutamine repeats, where 25Q is a benign poly-Q repeat that is not shown 
to aggregate, while 72Q is a pathologically toxic poly-Q length and is shown to be highly 
prone to aggregation and subsequent formation of inclusion bodies. Prior to oxidation, 
parkin runs as a distinctly monomeric species similar to 25Q, however upon exposure to 
H2O2, the parkin band begins to elongate, stretching the entire span from monomeric 
weight to the well after 2 hours exposure to 1 mM H2O2 (Figure 2.7). This process is 
accelerated in 5 mM H2O2, which is consistent with our previous analysis of these oxidation 
products with SDS-PAGE. Parkin runs as a smear that does not parallel completely with 
72Q; 72Q resides in the upper half of the gel length, which may indicate a heterogenous 
mixture of parkin-polymer lengths as a result of oxidation. Oxidation eventually causes the 
parkin to become insoluble and resistant to solubilization in 1% SDS conditions, an 
observation that could be a contributing factor to protein aggregation leading to LB 
formation. Parkin has been found in LB in PD patients that present with the protein 
aggregates (13), and these findings suggest oxidative stress may be a driving factor for LB 
formation in PD patients.  
Oxidation of parkin and its constructs gave rise to multiple species, so we looked 
to examine a possible oxidative pathway that the reaction proceeds along. By using band 
densitometry analysis, we were able to plot band intensities and monitor their changes as 
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oxidation occurred. In our analyses, having minimal background was absolutely crucial, 
therefore 141C gels were chosen for quantification, as full-length parkin had a larger 
molecular weight contaminant at time = 0 min, and 141C is more similar to the full-length 
parkin than Rcat is. We observed the formation of four distinct species on SDS-PAGE, 
unoxidized monomer, oxidized monomer, oxidized dimer, and any larger species were 
grouped as a polymer. Immediately after exposure to H2O2, the 141C formed a broader, 
faster migrating band, which is accompanied with an expected immediate loss of the initial 
unoxidized monomer (Figure 2.8). We assume that an intramolecular disulfide bond alters 
the conformation of 141C, making it more compact and thus migrating through the 
acrylamide gel slightly quicker. Our band densitometry analysis, however, measured a 
higher band intensity for the first oxidized time point than the initial, unoxidized protein 
by a factor of 1.5. As the unoxidized monomer band is a very narrow, compact band, it 
could be limited by the amount of stain uptake. Band densitometry of Coomassie stained 
proteins is inherently flawed, and results can be confounded by factors such as variations 
in dye binding between oxidized and unoxidized proteins, inaccuracy in integrating small 
areas during data analysis, and amount of dye compared to protein present is not an exact 
proportion (13).  
Therefore, band densitometry analysis should be interpreted with caution, and any 
analysis completed is not quantitative and should be look at for trends only. However, when 
comparing the same species over time, I was able to track the oxidized monomer, and in 
lower levels of oxidation it seemingly persists in a high proportion throughout the reaction, 
remaining in solution longer than the larger species. With very little delay, we see the 
formation of the dimeric species which peaks within the first few minutes of the reaction 
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in all conditions, occurring after the oxidized monomer. This species peaks at approximate 
0.2-0.3 intensity, then immediately begins to taper off as well, most likely as it becomes 
insoluble. The next species to form is the polymeric band. As this band was analyzed as a 
range between the trimer up to the gel well, it covers a wide range of molecular weight. It 
is apparent that these species form after dimer formation has occurred, then also falls out 
of solution. The data suggests an ordered, oxidative pathway (Figure 2.9), where oxidation 
modifies the initial proteins, which can then form dimers, followed by trimers and so on. 
This suggests a time dependent polymerization in an oxidative environment. As the 
oxidized monomer persists throughout the entire reaction, it could be indicating that more 
extensive polymerization in the form of intermolecular disulfide bonds occurs much more 
slowly, while intramolecular bonds form almost instantly. We can also posit that oxidation 
decreases the solubility of 141C and eventually causes it to precipitate. 
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Chapter 3  
3 Consequences and efficacy of Parkin oxidation: an 
interplay of cysteine and Zn2+ 
3.1 Introduction 
While our experiments thus far have yielded interesting results into the behaviour of parkin 
in an oxidizing environment relevant to the development and pathophysiology of some PD 
symptoms, I look to further establish the function and consequences of parkin as a redox 
molecule. As oxidation has been shown to chemically alter cysteine residues of parkin, I 
looked to explore further consequences of oxidation of cysteine’s thiol group, possibly 
effecting both structure and functionality of the enzyme.  
Although our mass spectrometry analysis is suggestive of the presence of oxidized 
cysteine disulfide linkages, I looked to take advantage of cysteine reactivity to further 
analyze oxidative dynamics, specifically the order in which cysteine oxidation occurs. 
Cysteine’s role in parkin is indispensable, with the majority of cysteine residues being 
responsible for coordinating 8 structural Zn2+ ions (1). One of the remaining cysteines 
participates in the catalytic function of parkin, while the remainder are not specifically 
assigned a functional role. Previous studies have shown an increase in labelling efficacy of 
the catalytic cysteine as an effect of parkin phosphorylation, but not in the case of pUb 
bound parkin, suggesting that while the latter does not induce a dramatic conformational 
change, full parkin activation plays a role in altering cysteine accessibility (2, 3). One study 
employed a mass spectrometry/tryptic digest approach to identify sites of oxidation, 
however, the study was limited to only identifying peptides containing oxidation (4). We 
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aim to expand on this approach by using a two-step alkylation protocol to elucidate which 
cysteines are more vulnerable to oxidation.  
 The vulnerability of cysteine oxidation is also essential for Zn2+ coordination. 
While some cysteines may exhibit varying degrees of solvent accessibility, this may 
translate into a possible mechanistically timed release of Zn2+ into the cytosol. Parkin binds 
8 Zn2+ ions and each of these Zn2+ binding sites may be distinct species that oxidize in 
different timepoints. This is significant, given that Zn2+ ion signalling operates at a 
dramatically lower effective concentration, within the range on 10-9 and 10-12 M, in 
comparison to Mg2+ and Ca2+, which operate between 10-3-10-6 and 10-6-10-9 M, 
respectively (5). If oxidative modifications of parkin facilitated Zn2+ release, this could 
allow oxidative stress to propagate a Zn2+-based signalling pathway. These signalling 
pathways would thus be a molecular switch that is sensitive to redox levels as cysteine 
thiols, which are redox sensitive, commonly coordinate Zn2+. Interestingly, Zn2+ itself is 
redox inert (5). Indeed, data has shown that some proteins have shown Zn2+-binding 
inhibition sites such as receptor protein tyrosine phosphatase β (6). 
 Concurrent with parkin’s ability to release Zn2+ is its obvious oxidation as a result of 
H2O2. However, parkin contains an extremely high proportion of cysteine ions; almost 4 
times that of the human proteomic average. This cysteine content could make parkin highly 
tolerable to oxidation, and indeed, one group recently proposed that parkin is a possible 
redox molecule (7). Parkin’s ability to directly reduce H2O2 in combination with its 
proximity to mitochondria may act as a buffering shield and make it well suited as a redox 
molecule. This chapter will elaborate on possibly essential consequences of parkin 
oxidation, as a potential redox and signalling molecule.   
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3.2 Materials and Methods 
3.2.1 Selective Cysteine labelling with iodoacetamide and N-ethyl 
maleimide 
Protein samples (parkin, 141C) at 10 µM were exposed to 1 mM H2O2 for a total of 5 or 60 
minutes and excess hydrogen peroxide was quenched with 5 mM ascorbic acid. Samples 
were then denatured with EDTA and reacted with 50 mM iodoacetamide (IAA) to alkylate 
free cysteines at 37 °C for 45 minutes. Excess IAA was quenched with 100 mM TCEP and 
100 mM DTT, incubating at 37 °C for 45 minutes, while also reducing cysteines back to 
the thiol form. Samples were then reacted with 300 mM N-ethyl maleimide (NEM), in 
excess of reducing reagent, to label newly reduced cysteines at 37°C for 45 minutes. 
Samples were then digested with Lys-C at 1:50 protein:Lys-C ratio at 37°C with shaking 
for 3 hours, then Trypsin was added at a 1:30 ratio and incubated overnight. Samples were 
analyzed by MS as described above, and data was processed using PEAKS software.  
 
3.2.2 Circular Dichroism Spectroscopy  
Circular dichroism spectroscopy experiments were performed using a JASCO J-810 CD 
spectropolarimeter equipped with a Peltier temperature control. A 1 mm path length cuvette 
was used. In all experiments, proteins were buffer exchanged into 100 mM NaCl, 25 mM 
Tris, pH 8.0. All data were fit using GraphPad Prism to determine denaturation midpoint 
as previously described. 
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3.2.3 Zn2+ release analysis using Zincon  
Protein samples were reacted in 100 µL volumes in buffer containing 50 mM CHES, pH 
9.0. Samples contained either 10 µM parkin or 141C, with or without pUb in a 1:1 ratio. 
40 µM Zincon was used for detection, and reactions were initiated with 5 mM H2O2. 
Concurrent reactions were conducted to monitor the reaction on SDS-PAGE. Microplate 
sample absorbance was measured using a Synergy H1 Microplate reader (Biotek) with 
kinetic scanning at a wavelength of 620 nm. Absorbance data was converted to 
concentration using Beer’s Law using an extinction coefficient for Zincon-Zn2+ complex 
of 25050 M-1cm-1. The path length was determined using height of a 100 uL sample in a 
well with a diameter of 6.94 mm, which equals a sample height of 0.28 cm. Data were 
analyzed using Prism. 
 
3.2.4 H2O2 Scavenging Assay using Amplex Red 
The scavenging rate of parkin was determined by reacting residual hydrogen peroxide 
(H2O2) with Amplex UltraRed (Thermo Fisher) in a horseradish peroxidase (HRP) 
catalyzed reaction, and measuring fluorescence intensity of the resulting molecule, 
resorfurin. Parkin, ubiquitin and catalase (CAT-SKL) were added in various concentrations 
to 5 µM H2O2 in a 60 µL reaction volume. Samples were incubated for 30 minutes at room 
temperature, at which point 50 µL of the reaction volume was added to 50 µL mixture 
containing 100 µΜ Amplex UltraRed and 0.2 U/mL of HRP in a 96-well microplate. The 
new mixture was incubated at room temperature for 15 minutes. Sample fluorescence 
intensity was measured using a Synergy H1 microplate reader (Biotek) using settings for 
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excitation wavelength of 530 nm and emission wavelength of 590 nm, as the 
excitation/emission maxima are 568/581 nm for the Amplex UltraRed. 
 
3.2.5 Ubiquitination assay. 
Parkin was oxidized in the same manner as described in Chapter 2. Oxidized parkin 
material was used in ubiquitination assays. These assays were monitored by a modified 
recombinant ubiquitin containing an N-terminal cysteine residue labelled with DyLight 
800 Maleimide (Ub800; Thermo Fisher Scientific) as previously described ((8, 9) All 
reactions were performed at 37°C and contained 1 µM wild type or oxidized parkin, 0.5 
µM UbcH7, 0.1 µM Uba1, 4 µM Ub, 0.5 µΜ pUb and 0.5 µM Ub800 in 5 mM MgATP, 
50 mM HEPES (pH 7.5). The ubiquitination reactions were quenched with 3×SDS sample 
buffer and 1 M DTT. 4–12% Bis-Tris gradient gels (Thermo Fisher Scientific) were used 
with MES running buffer (250 mM MES, 250 mM Tris, 0.5% SDS and 5 mM EDTA, pH 
7.3). Fluorescence intensity at 700 and 800 nm was measured using an Odyssey Imaging 
System (LI-COR). 
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3.3 Results 
3.3.1 Cysteine labelling 
The mass spectrometry results showed only a small proportion of cysteines being oxidized, 
from as few as two in some cases and up to seven in the case of 141C. While parkin has 35 
cysteines that may have varying degrees of exposure to solvent, we used a 2-step alkylation 
protocol in tandem with mass spectrometry to examine which cysteines are more 
susceptible to oxidation. Our protocol involved first oxidizing the protein in its native form 
to preserve its natural conformation. The oxidation was then quenched, and the protein was 
denatured and alkylated with IAA, creating a carbamidomethyl (CAM) adduct on any 
cysteines that was unaffected by oxidation. By then reducing the protein then alkylating 
with a second reagent, I was able to identify which cysteines were vulnerable to initial 
oxidative modifications. When parkin was exposed to 1mM H2O2 for 5 minutes, the protein 
digest was able to detect 335/465 residues of the sequence for full length parkin, which 
covers 25/35 of cysteine residues. I was only able to detect C421 labelled with NEM 
(Figure 3.1). However, when parkin was exposed to the same amount of H2O2 for 1 hour 
we were unable to obtain the same amount sequence coverage of parkin, detecting 279/365 
residues and three less cysteine residues. I was able to detect cysteine residues C166, 169, 
C421, C436 and C441 labelled with NEM (Figure 3.2). It is interesting to note that while 
these residues were the only ones detected with NEM within the entire sequence, they are 
seemingly clustered together, with the former two being detected within 3 residues of each 
other in the RING0 domain and the latter three occurring within the Rcat domain. When 
the 141C construct was subjected to the same 1-hour long treatment at 1 mM H2O2, I was 
only able to detect 172/325 residues and 22/35 cysteines. However, we were able to cover 
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the majority of the Rcat domain, with the exception of a stretch of 13 resides from 443-
455. While only one residue was labelled with NEM, C441, it is consistent with the 
cysteine residues that were oxidized in full-length parkin (Figure 3.3). 
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Figure 3.1. Peptide coverage map of parkin exposed to 1 mM H2O2 for 5 minutes. 
Parkin was exposed to 1 mM H2O2 for 5 minutes, alkylated with IAA, reduced with TCEP, then 
subsequently labelled using NEM. IAA modified cysteines are labelled with carbamidomethyl (CAM) 
groups (orange), while NEM incorporates an NEM group (light blue). Samples were digested with Lys-C 
and trypsin. Peptides were analyzed using an LC—ESI-MS Orbitrap Elite mass spectrometer 
(ThermoFisher Scientific) and data were analyzed using PEAKS software. 
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Figure 3.2. Peptide coverage map of parkin exposed to 1 mM H2O2 for 60 minutes. 
Parkin was exposed to 1 mM H2O2 for 60 minutes, alkylated with IAA, reduced with TCEP, then 
subsequently labelled using NEM. IAA modified cysteines are labelled with carbamidomethyl (CAM) 
groups (orange), while NEM incorporates an NEM group (light blue). Samples were digested with Lys-C 
and trypsin. Peptides were analyzed using an LC—ESI-MS Orbitrap mass spectrometer (ThermoFisher 
Scientific) and data were analyzed using PEAKS software. 
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Figure 3.3. Peptide coverage map of 141C exposed to 1 mM H2O2 for 60 minutes. 
141C was exposed to 1 mM H2O2 for 60 minutes, alkylated with IAA, reduced with TCEP, then 
subsequently labelled using NEM. IAA modified cysteines are labelled with carbamidomethyl (CAM) 
groups (orange), while NEM incorporates an NEM group (light blue). Samples were digested with Lys-C 
and trypsin. Peptides were analyzed using an LC—ESI-MS Orbitrap mass spectrometer (ThermoFisher 
Scientific) and data were analyzed using PEAKS software. 
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3.3.2 CD spectroscopy analysis 
As cysteine-Zn2+ coordination is an essential component of parkin’s structure, we used CD 
spectroscopy to analyze parkin’s dependence on cysteine oxidation state for structural 
integrity. In our analysis, we measured the secondary structure content of wild type parkin, 
parkin exposed to H2O2, and finally parkin in the presence of reducing agent for 1 and 3 
hours after oxidation. Spectral analysis of untreated parkin between 200-280 nm revealed 
local minima at 208 and 222 nm, typical of alpha helical structure. The minima present at 
208 nm is much greater in magnitude, polarizing light approximately -30 mdeg, in 
comparison to the minima at 222 nm, with an intensity of approximately -20 mdeg. 
Interestingly, very little change occurred in parkin’s spectrum as a result of oxidation, with 
possibly a very minor decrease in intensity at 222 nm. However, more dramatic changes 
occur as a result of subsequent reduction, as the minima at 222nm decreases in intensity of 
approximate 13 mdeg after exposure to reducing agent for 1 hour, and slight further 
decrease after 3 hours of exposure. 
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Figure 3.4 CD spectroscopy analysis of parkin in various states of redox. 
Parkin circular dichroism spectra from 200-280nm was measured for untreated parkin (black), parkin 
oxidized with 5mM H2O2 for 5 minutes then quenched (red), then treated with 50 mM TCEP for 1 (orange) 
and 3 hours (green). Experiments were performed using a JASCO J-810 CD spectropolarimeter equipped 
with a Peltier temperature control. A 1 mm path length cuvette was used. All experiments were conducted 
in buffer containing 100 mM NaCl, 25 mM Tris pH 8.0 
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3.3.3 Parkin is a mild scavenger of reactive oxygen species 
While our assays thus far have been designed to observe the consequences of oxidation on 
parkin, in order to support our hypothesis of parkin as an effective scavenger of ROS, we 
aimed to quantify the rate of H2O2 clearance. We used an Amplex UltraRed and horseradish 
peroxidase (HRP) linked assay. HRP catalyzes a reaction between the Amplex reagent with 
H2O2 in a stoichiometric 1:1 ratio, producing resorfurin, a fluorescent molecule. By 
incubating increasing amounts of ubiquitin, parkin and catalase with hydrogen peroxide 
for 30 minutes, we were able to assay the remaining amount of H2O2 after protein 
reduction. As a negative control, ubiquitin was mostly redox inert and was only able to 
decrease H2O2 from 5 µΜ to approximately 4 µΜ with up to 2 µΜ of ubiquitin added, 
showing very little difference as a function of ubiquitin concentration. On the other hand, 
catalase was used as a positive control was able to scavenge all H2O2 with 0.25 µΜ of 
protein to virtually nothing. Interestingly parkin shows a moderate ability to scavenge 
H2O2, and was able to clear approximately 1.5 µΜ of H2O2 with only 0.25 µΜ protein. This 
effect is dose dependant, with parkin clearing almost 3 µΜ H2O2 when 2 µΜ of parkin was 
added. 
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Figure 3.5. Hydrogen peroxide scavenging assay. 
Various concentrations of ubiquitin (black), parkin (red) and catalase (green) were incubated with 5 µΜ 
H2O2 for 30 minutes. Residual H2O2 was then reacted with an Amplex UltraRed/HRP based assay to 
generate resorfurin. Resofurin was monitored by fluorescence with excitation/emission values of 530/590 
nm. Measurements were taking using a Synergy H1 microplate reader.  
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3.3.4 Zn2+ ions are liberated in the presence of oxidation 
As cysteines are critical in the coordination of Zn2+, I looked to quantify the dynamics of 
Zn2+ release as a consequence of oxidation. I used Zincon, a Zn2+ binding reagent with a 
measurable change in UV absorbance when in complex with a Zn2+. I was able to create 
an` assay containing our protein of interest and Zincon in solution, and oxidation is initiated 
by the addition of H2O2. Absorbance changes were monitored using a BioTek Synergy H1 
microplate reader. I measured the change in Zincon-Zn2+ concentration of samples 
containing 10 µM parkin or 141C, both in the presence and absence of phosphorylated 
ubiquitin. For wild type parkin, we observed a sigmoidal curve with an inflection point 
approximately 20 minutes into the reaction. The curve reaches a maximum of 20 µM 
released Zn2+. Parkin is capable of binding 8 Zn2+ ions per protein molecule so 
stoichiometrically, 10 µM of parkin will contain 80 µM of Zn2+. The release of 20 µM of 
Zn2+ ions corresponds to the liberation of 2 Zn2+ per parkin molecule. The binding curve 
reaches saturation and is maintained for at least 30 minutes (Figure 3.6A). While in the 
presence of pUb, there was no distinguishable difference in Zn2+ release rates as error bars 
overlapped.  
When 141C was tested, the inflection point occurred earlier at approximately 15 
minutes, in comparison to the full-length parkin. Interestingly, the addition of pUb was 
able to slow down the rate of Zn2+ liberation, causing each curve to inflect approximate 3 
minutes later than usual (Figure 3.6B).  
 While the reactions occurred, samples were taken to track using SDS-PAGE. 
Interestingly, while the protein was oxidized at 5 mM H2O2, the rate of protein precipitation 
was dramatically decreased, parkin remained detectable, albeit in purely a high molecular 
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weight form, throughout the entire 2 hours reaction (Figure 3.6C). This is  in contrast to 
parkin oxidation in the absence on Zincon/ Zn2+ scavenging (Figure 2.4C). 
 
 
 
 
 
 
 
Figure 3.6. Zn2+ release assay of Parkin and 141C. 
10 µM of Parkin (A) and 141C (B) were oxidized in 5 mM H2O2 in the presence of Zn2+on. pUb was 
added in a 1:1 ratio for both proteins (red), or was absent (black). An SDS-PAGE gel of parkin being 
oxidized at 5 mM over a 2 hour time course to monitor oxidation. 
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3.3.5 Parkin ubiquitination activity is abolished in oxidizing conditions. 
While thus far I have established the structural consequences of parkin oxidation, I have 
yet to examine the effect of oxidation on the primary function of parkin as an E3 ubiquitin 
ligase (Figure 3.7). Methods for analyzing parkin’s ubiquitination activity has been well 
established (8). By providing parkin with Uba1, UbcH7, ATP, Ub and pUb, parkin will 
have access to all the components required to ubiquitinate a substrate. In order to visualize 
this reaction, a proportion of Ub is labelled with a fluorescent dye, allowing us to detect 
ubiquitination in the form of free and parkin-attached polyubiquitin chains, which is 
observed by a laddering pattern as ubiquitin is sequentially attached. The laddering 
eventually becomes a smear as resolution becomes lower in higher molecular weight 
ranges. By exposing parkin to 5 mM H2O2 then quenching the oxidation, I was able to 
obtain a series of increasingly oxidized parkin protein, similar to Figure 2. Each form of 
parkin was used in a ubiquitination assay to test the ability to ubiquitinate a substrate, in 
this case another parkin molecule, after exposure to oxidation. As expected, I observed 
ubiquitination activity in the unoxidized parkin as indicated at time = 0 min. Interestingly, 
I was able to observe a slight increase in ubiquitination when parkin was oxidized for 2 
minutes. This activity remains slightly elevated but tapers off at the 15-minute time point, 
at which point the activity is comparable to that of the unoxidized protein. After 30 minutes 
of oxidation, parkin is no longer active.  
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Figure 3.7. Ubiquitination assay with parkin oxidized at various time points. 
Parkin, was pre-oxidized and used in a functional ubiquitination assay. Protein ubiquitination is indicated 
by sequentially increasing steps, indicating ubiquitination addition onto parkin. Time refers to the length 
of time parkin was exposed to 5 mM H2O2. 
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3.4 Discussion 
Oxidation of parkin peptides has been previously established (4) with the limitation that 
only peptides that contained sulfonation were detected. Our mass spectrometry data also 
showed a total of 5 distinct cysteine residues that were vulnerable to oxidation, as 
evidenced by a very small cluster of cysteine residues exhibited NEM modifications 
surrounding the catalytic cysteine, C431 and a pair of cysteines in the RING0 domain. 
Interestingly, across all three oxidation experiments, C432 was not shown to be oxidized 
in any scenario (Figure 3.1-3.3). This comes as a surprise as previous data has shown the 
C431 is indeed solvent accessible (10). This may indicate that the catalytic cysteine is more 
resistant to oxidation. While oxidation has previously been shown to abolish parkin 
function (4), and is corroborated by data I present here, the mechanism in which this occurs 
must not directly affect the catalytic cysteine, and must instead be the cause of a structural 
collapse. Indeed, the C166 and C169 coordinate the same cysteine, as do C421, C436 and 
C441. This suggest a Zn2+ site targeted cascade of oxidation, were oxidation of one residue 
may then cause collapse of that coordination site and render other residues vulnerable to 
oxidation. However, the RING0 and Rcat domains remains highly vulnerable to oxidation, 
which would compromise structural integrity due to loss Zn2+ ion coordination.  
The overall structure as analyzed by CD spectropolarimetry was interesting. The 
untreated parkin had a very similar spectrum to that of the oxidized parkin; changes were 
not visible until we started to reduce the protein. There was a loss of alpha helical structure 
after reduction with TCEP. A previous study has established a correlation between alpha 
helical structure content and 222/208 ratio; where a ratio of 1.1 or greater is diagnostic of 
coiled-coils, while a ratio of 0.9 or less indicates more isolated helix structure (11). The 
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distinct loss of the intensity at 222 nm as a result of reduction is consistent with the loss of 
a coiled coil structure (Figure 3.4).  Overall, this may indicate that mild oxidation was 
beneficial to the structure and function of parkin, similar to DJ-1, another PD implicated 
protein that requires oxidation in order to be fully activated (12). This is supported by our 
ubiquitination activity assay (Figure 3.7), where initial oxidative insult to parkin caused 
an increase in ubiquitination activity. While it is proposed that DJ-1 utilizes the oxidation 
of its cysteine thiol to a sulfinic acid as a molecular redox switch, parkin may utilize the 
conveniently available oxidation that it is exposed to during activation to further augment 
the activation signal. 
We then compared parkin’s ability to act as a redox scavenger of H2O2. 
Unsurprisingly, catalase was able to clear all H2O2 at our lowest tested concentration. 
However, parkin, when compared to the relatively redox-inert ubiquitin, was able to clear 
a greater than 1:1 ratio of parkin to hydrogen peroxide. While we may expect more of 
parkin, given the fact it contains 35 cysteines, the proof of principle may apply in a much 
more chronic, long term exposure as would be relevant in PD. While our experiments could 
have utilized smaller H2O2 concentrations for longer time points, the time-scale is several 
orders of magnitudes shorter than parkin would be subjected to in a pathological PD 
patient.  
Interestingly, few studies have been conducted with regards to parkin-Zn2+ release 
as a result of oxidation. The importance of parkin’s Zn2+ content is underscored by the fact 
that not only does parkin coordinate an impressive 8 Zn2+, but that Zn2+ is considered the 
most sensitive redox-inert ion signalling molecules (5). Our data showed only two Zn2+ 
were liberated as a result of parkin oxidation (Figure 3.6). In only 2 Zn2+ can be released 
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from parkin via oxidation, this will put parkin within the realm of other metalloproteins 
and likely not result in extensive Zn2+ mediated signalling. However, the possible release 
of all of parkin’s ions indicate the potential for a physiologically significant role in Zn2+ 
signalling. Interestingly, when monitoring our Zn2+ release assay with SDS-PAGE we 
observed a dramatically slower oxidation rate in comparison to our initial oxidation assays 
(Figure 2.3C). We propose that Zincon, which is capable of binding and sequestering free 
Zn2+ ions, is acting in a Zn2+ buffering capacity in our reaction. While previous protein 
precipitation was attributed to the loss of Zn2+ coordination, a possible mechanism is free 
Zn2+ negatively impacting the protein structure.  
 We have thus far demonstrated two possible novel functions of parkin as both a 
redox molecule and a redox sensitive Zn2+containing protein. Also, we have shown that the 
catalytic cysteine is not preferentially oxidized (Figure 3.1-3.3). Interestingly, parkin 
exhibits an increase in activity when oxidized for a short time frame, and then the function 
is lost, presumably due to oxidative damage.  These results are consistent with another 
study which displayed parkin upregulation after exposure to H2O2 in vivo (4). While the in 
vivo study rationalized the upregulation of parkin as a mechanism due to initial 
mitochondrial signalling and subsequent recruitment and activation of parkin, our 
experiment was conducted in vitro, which may suggest a molecular mechanism of parkin 
activation as a result of oxidation. While oxidation would certainly hinder cysteine 
function, parkin still contains 4 cysteine residues that are not known to be catalytic or 
structural. This could indicate an oxidation mediated stabilization of activation of parkin 
that mirrors that of DJ-1, which has been shown to have a highly conserved cysteine residue 
that is required to confer a neuroprotective function.  
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Chapter 4  
4 Summary of Thesis 
4.1 Parkin is a redox sensitive molecule 
The oxidation of parkin has provided insight into several interesting possibilities in its 
cellular function. While PINK1/parkin has been established as one of primary pathways 
leading to mitochondrial degradation (1), little is known about the pathogenesis of PD 
when these proteins are affected. Parkin oxidation has shown form reversible high 
molecular weight oligomers (Figure 2.3), which are mediated by disulfide linkages. This 
process has been shown to followed an ordered pathway, as oxidation cause parkin 
oligomers to sequentially grow over time (Figure 2.10). Studies have shown an association 
of parkin to the periphery of LB’s (2), and although extensive oxidation causes the 
formation of insoluble oligomers, the reducibility of these oligomers would distinguish 
them from the true fibrillar aggregates of SNCA that make up the majority of LB’s. 
Assessment of LB’s content may be subject to further proteomic analysis, and whether or 
not the proteins in LB’s are extensively oxidized. The oxidation of parkin has been shown 
to cause disulfide linked oligomerization, which eventually proceeds to insolubility. The 
formation of insoluble fibril-like aggregates is eerily similar to the aggregation mechanism 
of SNCA which may suggest a mechanistic of parkin implication in LB’s. The similarity 
of these aggregates to SDS-resistant aggregates found in Huntington’s disease (Figure 
2.8), another neurodegenerative disease is possible evidence of parkin’s’ involvement in 
neuronal plaque formation. Interestingly, we observed that parkin maintains solubility 
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when oxidized in the presence of a zinc binding reagent (Figure 3.6B). This could possibly 
allude to a zinc toxicity mechanism that promotes insolubility of proteins. 
While parkin may primarily function as an E3 ligase to signal mitophagy, we 
suspect that parkin exposure to oxidation would necessitate a structure that is redox 
tolerant, and that parkin may also have to function as a redox scavenger. Ubiquitination 
activity is upregulated for a short time frame after exposure to oxidation. While this is 
consistent with a study displayed parkin upregulation after exposure to H2O2 in vivo (3), 
our experiment was done without the cellular context required for protein activation. 
Therefore, our in vitro study is suggestive of an isolated, molecular cause of parkin 
activation. Another PD-implicated gene is the DJ-1 protein, which very readily converts 
its Cys106 to a Cys106-sulfonate (Cys106-SO3-) (4). This conversion stabilizes DJ-1 as the 
sulfonate side chain forms three hydrogen bonds to surrounding residues (5). Parkin 
contain four additional cysteine residues that do not participate in catalysis or Zn2+ 
coordination, and could possibly function as a redox sensitive module for further parkin 
stabilization. This stabilization could possibly be used to mediate favorable interaction 
between parkin and UbcH7, Ub or pUb.  
As parkin is able to be oxidized beyond the point of function loss (Figure 2.3, 3.7) 
we explored the possibility of parkin as a redox molecule. Considering both the localization 
and high cysteine content of parkin, it would be well suited as a convenient, non-enzymatic 
source of redox molecules. The comparing the efficacy of H2O2 clearance rates of parkin 
to ubiquitin, parkin is able to at least clear H2O2 at close to a 1:1 ratio, while ubiquitin was 
mostly redox-resistant. However, our assay was limited by the range of H2O2 clearance 
when compared to catalase, which was able to immediately deplete all H2O2 almost 
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immediately at all concentrations tested (Figure 3.5). Further analysis of the effective 
range of parkin’s H2O2 scavenging ability should be conducted. 
 
4.2 Oxidative consequences of Zn2+ liberation 
The structural and functional consequences of parkin oxidation have been studied in the 
past and elaborated upon in this study, however we look at a novel concept of parkin. 
Parkin’s ability to coordinate eight Zn2+ ions was partially abolished as a result of oxidation 
(Figure 3.6A-B), causing the release of two Zn2+ ions per molecule of parkin. 
Concurrently, we have shown that oxidation also causes a degradation of coiled-coil 
structure (Figure 3.4). Taken together, we can postulate that a coordinated coiled coil 
structure may be essential for at least 2 Zn2+ coordination. As we can also detect a slight 
upregulation of parkin ubiquitination activity (Figure 3.7).  If the local concentration of 
parkin at the mitochondrial periphery high enough, this could cause a significant increase 
in free Zn2+ ion concentration. This is supported by the fact that Zn2+ ion signalling is 
extremely sensitive, operating at free ion concentration between 10-9 and 10-12 M. This 
range is dramatically lower than that of either Ca2+ and Mg2+ by factors of 1000 and 
1000000, respectively. Zn2+ is also a redox inert ion, which would be advantageous in a 
redox sensitive molecular signalling system.  
 
4.3 Future directions  
The research outlined in this thesis aimed to explore novel functions of parkin: specifically, 
the ability to act as a ROS scavenger and a potential Zn2+ signalling molecule. While the 
currently established function of parkin is to act as an E3 ligase to induce mitophagy, 
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structural components of parkin including high cysteine and Zn2+ content, in addition to its 
localization to the periphery of the mitochondria could have certain implications for the 
overall health of the cell. We discuss parkin’s ROS scavenging efficacy, but were limited 
by the overall effective range of H2O2 clearance. As there is a massive disparity between 
the H2O2 clearance rates of parkin and catalase, does not possibly diminish parkin’s 
contribution as an anti-oxidant. We suggest that further studies may quantify the rates of 
H2O2 clearance to demonstrate a physiologically relevant level that would be beneficial. In 
vivo studies could also be conducted with special regard to clearly delineating between 
parkin ligase activity and direct redox potential, potentially through the use of a 
catalytically dead mutant.   
While parkin oxidation also results in Zn2+ ion liberation, it would be crucial to 
quantify the flux of free Zn2+ ions and whether the signal was significant enough to elicit a 
response. Further research into the cellular effects of zinc increase should be conducted to 
assess whether these activated pathways have a synergistic effect in either mitochondrial 
clearance, rescue from oxidative stress or even cellular apoptosis. This discovery could 
establish multiple function of parkin as a redox molecule as well as a reserve of Zn2+ ions. 
We propose that a possible mechanism where mitochondrial depolarization and subsequent 
ROS generation exceeds the cells ability to carry out mitophagy. In this situation, activated 
parkin that is recruited to the mitochondria can carry out a “sacrificial lamb” function, 
consuming itself as a redox molecule and in the process cause a significant increase of free 
Zn2+ ions.  
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4.4 Significance of Work 
As of the date of this study, only speculation exists on how the manifestation of PD occurs. 
In this study, we provide a possible mechanism of parkin aggregation and promotion of LB 
formation, which may provide insight into the development of PD. As our study especially 
focussed on the structural and functional consequences of parkin oxidation in PD, this may 
provide valuable insight into antioxidant-based therapies in order to combat or delay the 
onset of PD. Furthermore, we provide plausible, novel mechanisms of parkin, which may 
supplement the well-established ligase activity of parkin and set the foundation for research 
beyond what is already known. 
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